Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Could COVID-19 Cause Type 1 Diabetes?
    Health

    Could COVID-19 Cause Type 1 Diabetes?

    By University of HelsinkiApril 20, 20231 Comment4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    COVID World
    A study conducted by the University of Helsinki identified a 16% increase in type 1 diabetes among Finnish children during the first 18 months of the pandemic. However, this increase was not attributed to the coronavirus but rather altered environmental factors due to societal lockdowns and social isolation.

    A Finnish study attributes a pandemic-era rise in type 1 diabetes among children to reduced microbial exposure from lockdowns rather than COVID-19 infections.

    A recently concluded study has revealed that during the initial 18 months of the COVID-19 pandemic, a higher number of minors in Finland than usual were diagnosed with type 1 diabetes. The research findings indicate that the cause of this increase was not the virus itself, but rather changes in environmental factors.

    The global rise in the occurrence of type 1 diabetes during the COVID-19 pandemic has been the subject of investigation by the PEDIA research group at the University of Helsinki. Their focus has been on exploring the phenomenon and identifying the causes among children in Finland.

    “The mechanisms of the increase in the incidence of diabetes have been unclear, and there has been discussion on whether the increase results from a direct effect of SARS-CoV-2 infection or other simultaneously altered environmental factors,” says Professor Mikael Knip, who headed the study.

    According to the study, the incidence of type 1 diabetes increased in children in Finland by 16% in the first 18 months of the pandemic. However, very few children or adolescents who developed type 1 diabetes had SARS-CoV-2 antibodies indicating past infection.

    According to the researchers, the increase in the incidence of type 1 diabetes in the early stages of the pandemic is not likely to have been caused directly by coronavirus. Instead, it may be related to the society-wide lockdown during the pandemic period and the resulting social isolation.

    “According to what is known as the biodiversity hypothesis, microbial exposure and infections in early childhood can boost the protection against autoimmune diseases. The reduction in contacts in connection with the societal lockdown significantly reduced acute infections in children, which may have increased the risk of developing diabetes,” Knip explains.

    The results were published in the Lancet Diabetes & Endocrinology journal.

    Is the Increase in the Incidence of Pediatric Diabetes Temporary?

    In the study, the incidence of type 1 diabetes in Finns under 15 years of age was compared to three preceding reference periods of the same duration. SARS-CoV-2 antibodies in children with type 1 diabetes were analyzed in collaboration with Professor Olli Vapalahti’s research group. Among the 785 children and adolescents diagnosed with type 1 diabetes in the pandemic period, infection-induced SARS-CoV-2 antibodies were found in only five individuals, i..e. less than 1%.

    “The matter must be investigated further to find out what has happened to the incidence of type 1 diabetes since the lifting of the lockdown in summer 2021 and the subsequent increase in the number of coronavirus infections in the population,” Professor Vapalahti notes.

    Registers Are Important Sources of Data

    “The study was based on data from the Finnish Pediatric Diabetes Register,” says Mikael Knip, the Principal Investigator in charge of the register.

    Since 2002, data and samples from the newly diagnosed children and their family members have been collected in this national register. The register, maintained by HUS Helsinki University Hospital, covers more than 90% of the patients who have developed diabetes.

    “The register is globally unique including both data and biological samples and provides irreplaceable data for research,” Knip concludes.

    Reference: “SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study” by Prof Mikael Knip, MD; Anna Parviainen, MD; Maaret Turtinen, MD; Anna But, Ph.D.; Taina Härkönen, Ph.D.; Jussi Hepojoki, Ph.D.; Tarja Sironen, Ph.D.; Rommel Iheozor-Ejiofor, MSc; Hasan Uğurlu, MSc; Prof Kalle Saksela, MD; Johanna Lempainen, MD; Prof Jorma Ilonen, MD; Prof Olli Vapalahti, MD and the Finnish Pediatric Diabetes Register, April 2023, The Lancet Diabetes & Endocrinology.
    DOI: 10.1016/S2213-8587(23)00041-4

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    COVID-19 Diabetes University of Helsinki
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    A Common Risk Factor for Alzheimer’s Disease May Predispose Carriers to Severe COVID-19, Cerebral Microhemorrhages

    Lowering Your Blood Insulin Levels Could Lower Risk of Getting COVID-19

    New COVID-19 Treatment for People With Diabetes Shows Early Promise

    Why People With Diabetes Develop Severe COVID-19 – Mechanism Behind Coronavirus Cytokine Storms Revealed

    Artificial Intelligence Model Predicts Which Immune System Key Opens the Locks of Coronavirus

    Tsunami of Chronic Health Conditions Expected as a Result of COVID-19 Pandemic – Will Affect Society for Decades

    New Data on COVID-19 Patients With Diabetes: 20% Die Within 28 Days of Hospital Admission

    Two-Thirds of COVID-19 Hospitalizations Are Due to These Four Conditions

    Obesity Linked With Higher Risk for Coronavirus Complications – May Spell Problems for COVID-19 Vaccine

    1 Comment

    1. michael on April 21, 2023 10:01 pm

      Is the “deadly” virus being blamed (again) for an already-scientifically confirmedside-effect of the experimental gene therapy treatment “vaccines”.
      Could be, according to this report from a generally highly-reliable source, which concludes, “. . . COVID-19 RNA-based vaccines might trigger the onset of type 1 diabetes, even in subjects without prior histories of diabetes.
      https://pubmed.ncbi.nlm.nih.gov/35220662/

      Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    New Pill Lowers Stubborn Blood Pressure and Protects the Kidneys

    Humans May Have Hidden Regenerative Powers, New Study Suggests

    Scientists Just Solved the Mystery of Why Crabs Walk Sideways

    Doctors Are Surprised by What This Vaccine Is Doing to the Heart

    This Popular Supplement May Boost Your Brain, Not Just Your Muscles

    Scientists Say This Simple Supplement May Actually Reverse Heart Disease

    Warming Oceans Could Trigger a Dangerous Methane Surge

    This Simple Movement Could Be Secretly Cleaning Your Brain

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Warn of Rising Male Childlessness As Global Fertility Changes
    • New Discovery Challenges Decades-Old Theory of DNA Damage and Aging
    • Scientists Just Rewrote Biology: “Hidden” Mechanism Could Transform Diabetes Treatment
    • Scientists Solve 320-Million-Year Mystery of Reptile Skin Armor
    • Hidden Heart Risk Found in 1 in 5 People, Study Warns
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.